Show simple item record

dc.contributor.authorPotter, G. A.
dc.contributor.authorPatterson, L. H.
dc.contributor.authorWanogho, E.
dc.contributor.authorPerry, P. J.
dc.contributor.authorButler, P. C.
dc.contributor.authorIjaz, T.
dc.contributor.authorRuparelia, K. C.
dc.contributor.authorLamb, J. H.
dc.contributor.authorFarmer, B.
dc.contributor.authorStanley, L. A.
dc.contributor.authorBurke, M. D.
dc.date.accessioned2009-03-19T15:32:24Z
dc.date.available2009-03-19T15:32:24Z
dc.date.issued2002-01-15
dc.identifier.citationPotter, G. A. et al (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. British Journal of Cancer, 86 (5), pp. 774-778.en
dc.identifier.issn1532-1827
dc.identifier.urihttp://hdl.handle.net/2086/1371
dc.language.isoenen
dc.publisherNature Publishing Groupen
dc.subjectRAE 2008en
dc.subjectUoA 13 Pharmacyen
dc.titleThe cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.en
dc.typeArticleen
dc.identifier.doihttp://dx.doi.org/10.1038/sj.bjc.6600197
dc.researchgroupChemistry for Health


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record